Newsletter | November 8, 2022

11.08.22 -- Soluble Versus Insoluble Expression In Microbial Fermentation

Industry Insights
Soluble Versus Insoluble Expression In Microbial Fermentation

Expression of inclusion bodies has historically suffered a bad reputation in the industry. So, how do these two routes, soluble and insoluble, compare in terms of their advantages and challenges?

Master Analytical SEC Running Conditions

Need to find out how to calibrate your size exclusion chromatography (SEC) column? Or how different additives affect your results? Read these useful insights.

Balancing Cost Efficiencies In The Drug Development Process

Cost efficiencies and expertise again go hand in hand, with companies often outsourcing or partnering primarily to gain access to manufacturing know-how.

Integrated Predictive Sciences Solutions To Accelerate Drug Discovery

Learn how having the right predictive sciences capabilities integrated into R&D workflows delivers a scientific decision support environment that reduces time and expense, improves quality, enhances collaboration, and accelerates innovation in bringing new drugs to market.

Route Development: Designing Synthesis For GMP Production

The successful transition from initial synthesis of an API to a kilogram-scale route requires expert analysis and design and a balance of economic, regulatory, and time constraints.

The Key Enablers Of Late-Phase Biologics Development And Launch

Dr. Claudia Müller answers attendee questions from a webinar about the complex path to a successful product launch, which requires a holistic development strategy driven by a well-defined target product profile.

How To Choose The Best Filtration Device For Your Application

Learn how to choose the best filtration device for your specific application and understand pore size, membrane material, well volumes, and tip types.

Upcoming Industry Webinars
Novel Molecular Biologic Formats Require Tailored CMC Solutions

November 15, 2022 | 11:00 a.m. EST
New molecular formats and other recombinant proteins present facility- and product-specific development requirements that often render platform approaches inappropriate. Accordingly, addressing the most pressing challenges in process and analytical development associated with novel molecular biologic formats requires a keen understanding of the applicable tools and strategies.

Most Popular News
Life Science Leader Magazine

Have you heard of Life Science Leader?
Check it out today for access to candid interviews with top-tier executives on how they do business.